Jae-Joon Kim
Directeur/Membre du Conseil chez YOUCEL, Inc.
Fortune : 468 628 $ au 30/04/2024
Profil
Jae-Joon Kim currently works at Mirae Asset Venture Investment Co., Ltd., as Senior Managing Director, ImmunoMet Therapeutics, Inc., as Director from 2016, and YOUCEL, Inc., as Non-Executive Director.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/09/2023 | 114 030 ( 0,21% ) | 468 628 $ | 30/04/2024 |
Postes actifs de Jae-Joon Kim
| Sociétés | Poste | Début |
|---|---|---|
Mirae Asset Venture Investment Co., Ltd. /Venture Capital/
 Mirae Asset Venture Investment Co., Ltd. /Venture Capital/ Investment ManagersFinance Mirae Asset Venture Investment Co., Ltd. /Venture Capital/ (Mirae Asset Venture) is a private equity & venture capital subsidiary of Mirae Asset Venture Investment Co., Ltd. founded in 1999. The firm is headquartered in Seongnam, South Korea with an office in Seoul. | Private Equity Investor | 01/01/2018 |
ImmunoMet Therapeutics, Inc.
 ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Directeur/Membre du Conseil | 01/03/2016 |
YOUCEL, Inc.
 YOUCEL, Inc. BiotechnologyHealth Technology YOUCEL, Inc. engages in the manufacture and sale of cosmetics and pharmaceutical products. Its products include facial masks, cleansers, and hair and skin care products. The company was founded on August 18, 2008 and is headquartered in Iksan-si, South Korea. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Mirae Asset Venture Investment Co., Ltd. /Venture Capital/
Mirae Asset Venture Investment Co., Ltd. /Venture Capital/ Investment ManagersFinance Mirae Asset Venture Investment Co., Ltd. /Venture Capital/ (Mirae Asset Venture) is a private equity & venture capital subsidiary of Mirae Asset Venture Investment Co., Ltd. founded in 1999. The firm is headquartered in Seongnam, South Korea with an office in Seoul. | Finance |
ImmunoMet Therapeutics, Inc.
ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Health Technology |
YOUCEL, Inc.
YOUCEL, Inc. BiotechnologyHealth Technology YOUCEL, Inc. engages in the manufacture and sale of cosmetics and pharmaceutical products. Its products include facial masks, cleansers, and hair and skin care products. The company was founded on August 18, 2008 and is headquartered in Iksan-si, South Korea. | Health Technology |
